American Century Companies Inc Syndax Pharmaceuticals Inc Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$18.82 - $23.79 $184,492 - $233,213
9,803 New
9,803 $201,000
Q1 2023

May 11, 2023
BUY
$20.66 - $28.98 $80,656 - $113,137
3,904 Added 29.21%
17,267 $364,000
Q4 2022

Feb 13, 2023
SELL
$20.64 - $26.24 $68,772 - $87,431
-3,332 Reduced 19.96%
13,363 $340,000
Q3 2022

Nov 14, 2022
BUY
$18.51 - $24.79 $309,024 - $413,869
16,695 New
16,695 $401,000

Others Institutions Holding SNDX

# of Institutions
228
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $796M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email